CSPC Pharmaceutical rises most in eight weeks on drug registration nod

CSPC PHARMACEUTICAL

22/05/2026 04:19

** Shares of CSPC Pharmaceutical Group 1093.HK climb 7.2% to HK$7.87, on track for biggest one-day pct gain since March 27

** Stock touches the highest point since May 15 and on course to snap eight straight sessions of falls

** Chinese pharmaceuticals products producer said its budesonide enteric-coated capsules (4mg) have obtained drug registration approval from China's National Medical Products Administration (NMPA)

** Product is for treatment of adult patients with primary immunoglobulin A nephropathy and approval will expand group's product portfolio in nephrology therapeutic area - co

** YTD, stock down 7.2%, the Hang Seng Biotech Index .HSBIO down 3.6%

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))